Type I IFN signaling is crucial for host resistance against different species of pathogenic bacteria

被引:205
作者
Mancuso, Giuseppe
Midiri, Angelina
Biondo, Carmelo
Beninati, Concetta
Zummo, Sebastiana
Galbo, Roberta
Tomasello, Francesco
Gambuzza, Maria
Macri, Giancarlo
Ruggeri, Alessia
Leanderson, Tomas
Teti, Giuseppe
机构
[1] Univ Messina, Dipartimento Patol & Microbiol Sperimentale, Policlin Univ, I-98125 Messina, Italy
[2] Lund Univ, Immunol Grp, Lund, Sweden
关键词
D O I
10.4049/jimmunol.178.5.3126
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
It is known that host cells can produce type I IFNs (IFN-alpha beta) after exposure to conserved bacterial products, but the functional consequences of such responses on the outcome of bacterial infections are incompletely understood. We show in this study that IFN-alpha beta signaling is crucial for host defenses against different bacteria, including group B streptococci (GBS), pneumococci, and Escherichia coli. In response to GBS challenge, most mice lacking either the IFN-alpha beta R or IFN-beta died from unrestrained bacteremia, whereas all wild-type controls survived. The effect of IFN-alpha beta R deficiency was marked, with mortality surpassing that seen in IFN-gamma R-deficient mice. Animals lacking both IFN-alpha beta R and IFN-gamma R displayed additive lethality, suggesting that the two IFN types have complementary and nonredundant roles in host defenses. Increased procluction of IFN-alpha beta was detected in macrophages after exposure to GBS. Moreover, in the absence of IFN-alpha beta signaling, a marked reduction in macrophage production of IFN-gamma, NO, and TNF-alpha was observed after stimulation with live bacteria or with purified LPS. Collectively, our data document a novel, fundamental function of IFN-alpha beta in boosting macrophage responses and host resistance against bacterial pathogens. These data may be useful to devise alternative strategies to treat bacterial infections.
引用
收藏
页码:3126 / 3133
页数:8
相关论文
共 54 条
[1]   Myeloid differentiation factor 88-dependent signalling controls bacterial growth during colonization and systemic pneumococcal disease in mice [J].
Albiger, B ;
Sandgren, A ;
Katsuragi, H ;
Meyer-Hoffert, U ;
Beiter, K ;
Wartha, F ;
Hornef, M ;
Normark, S ;
Normark, BH .
CELLULAR MICROBIOLOGY, 2005, 7 (11) :1603-1615
[2]  
[Anonymous], 1999, WKLY EPIDEMIOL REC
[3]   Mice lacking the type I interferon receptor are resistant to Listeria monocytogenes [J].
Auerbuch, V ;
Brockstedt, DG ;
Meyer-Morse, N ;
O'Riordan, M ;
Portnoy, DA .
JOURNAL OF EXPERIMENTAL MEDICINE, 2004, 200 (04) :527-533
[4]   Early-onset neonatal sepsis in the era of group B streptococcal prevention [J].
Baltimore, RS ;
Huie, SM ;
Meek, JI ;
Schuchat, A ;
O'Brien, KL .
PEDIATRICS, 2001, 108 (05) :1094-1098
[5]   Inferences, questions and possibilities in toll-like receptor signalling [J].
Beutler, B .
NATURE, 2004, 430 (6996) :257-263
[6]   MyD88 and TLR2, but not TLR4, are required for host defense against Cryptococcus neoformans [J].
Biondo, C ;
Midiri, A ;
Messina, L ;
Tomasello, F ;
Garufi, G ;
Catania, MR ;
Bombaci, M ;
Beninati, C ;
Teti, G ;
Mancuso, G .
EUROPEAN JOURNAL OF IMMUNOLOGY, 2005, 35 (03) :870-878
[7]   Alpha/beta interferon impairs the ability of human macrophages to control growth of Mycobacterium bovis BCG [J].
Bouchonnet, F ;
Boechat, N ;
Bonay, M ;
Hance, AJ .
INFECTION AND IMMUNITY, 2002, 70 (06) :3020-3025
[8]   INTERFERON-ALPHA INCREASES THE FREQUENCY OF INTERFERON-GAMMA-PRODUCING HUMAN CD4+ T-CELLS [J].
BRINKMANN, V ;
GEIGER, T ;
ALKAN, S ;
HEUSSER, CH .
JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 178 (05) :1655-1663
[9]   MOUSE FIBROBLAST INTERFERON MODIFIES SALMONELLA-TYPHIMURIUM INFECTION IN INFANT MICE [J].
BUKHOLM, G ;
BERDAL, BP ;
HAUG, C ;
DEGRE, M .
INFECTION AND IMMUNITY, 1984, 45 (01) :62-66
[10]   INTERFERON-INDUCED INDOLEAMINE 2,3-DIOXYGENASE ACTIVITY INHIBITS CHLAMYDIA-PSITTACI REPLICATION IN HUMAN MACROPHAGES [J].
CARLIN, JM ;
BORDEN, EC ;
BYRNE, GI .
JOURNAL OF INTERFERON RESEARCH, 1989, 9 (03) :329-337